JP2013510577A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013510577A5 JP2013510577A5 JP2012538970A JP2012538970A JP2013510577A5 JP 2013510577 A5 JP2013510577 A5 JP 2013510577A5 JP 2012538970 A JP2012538970 A JP 2012538970A JP 2012538970 A JP2012538970 A JP 2012538970A JP 2013510577 A5 JP2013510577 A5 JP 2013510577A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- spore
- tissue
- isolated
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004027 cell Anatomy 0.000 claims description 32
- 210000001519 tissue Anatomy 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 10
- 239000003550 marker Substances 0.000 claims description 6
- 108090000397 Caspase 3 Proteins 0.000 claims description 4
- 102100029855 Caspase-3 Human genes 0.000 claims description 4
- 102100037124 Developmental pluripotency-associated 5 protein Human genes 0.000 claims description 4
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 4
- 101000881848 Homo sapiens Developmental pluripotency-associated 5 protein Proteins 0.000 claims description 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 4
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims description 4
- 101000603323 Homo sapiens Nuclear receptor subfamily 0 group B member 1 Proteins 0.000 claims description 4
- 101000864761 Homo sapiens Splicing factor 1 Proteins 0.000 claims description 4
- 101000697510 Homo sapiens Stathmin-2 Proteins 0.000 claims description 4
- 101000585255 Homo sapiens Steroidogenic factor 1 Proteins 0.000 claims description 4
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 4
- 102100025304 Integrin beta-1 Human genes 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 101100107167 Mus musculus Znf296 gene Proteins 0.000 claims description 4
- 102000008730 Nestin Human genes 0.000 claims description 4
- 108010088225 Nestin Proteins 0.000 claims description 4
- 102100039019 Nuclear receptor subfamily 0 group B member 1 Human genes 0.000 claims description 4
- 102000007354 PAX6 Transcription Factor Human genes 0.000 claims description 4
- 101150081664 PAX6 gene Proteins 0.000 claims description 4
- 102000007620 Pulmonary Surfactant-Associated Protein C Human genes 0.000 claims description 4
- 108010007125 Pulmonary Surfactant-Associated Protein C Proteins 0.000 claims description 4
- 101100127230 Rattus norvegicus Khdc3 gene Proteins 0.000 claims description 4
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 claims description 4
- 102100028051 Stathmin-2 Human genes 0.000 claims description 4
- 102100029856 Steroidogenic factor 1 Human genes 0.000 claims description 4
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 4
- 102100031083 Uteroglobin Human genes 0.000 claims description 4
- 108090000203 Uteroglobin Proteins 0.000 claims description 4
- 101000929049 Xenopus tropicalis Derriere protein Proteins 0.000 claims description 4
- -1 cKit Proteins 0.000 claims description 4
- 102000006495 integrins Human genes 0.000 claims description 4
- 108010044426 integrins Proteins 0.000 claims description 4
- 210000005055 nestin Anatomy 0.000 claims description 4
- 210000000936 intestine Anatomy 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- 210000004072 lung Anatomy 0.000 claims description 3
- 210000000496 pancreas Anatomy 0.000 claims description 3
- 210000001525 retina Anatomy 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 claims description 3
- 210000003932 urinary bladder Anatomy 0.000 claims description 3
- 241000271566 Aves Species 0.000 claims description 2
- 241000270322 Lepidosauria Species 0.000 claims description 2
- 210000004100 adrenal gland Anatomy 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 210000003981 ectoderm Anatomy 0.000 claims description 2
- 210000001900 endoderm Anatomy 0.000 claims description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims description 2
- 210000002216 heart Anatomy 0.000 claims description 2
- 210000003716 mesoderm Anatomy 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26060709P | 2009-11-12 | 2009-11-12 | |
| US61/260,607 | 2009-11-12 | ||
| PCT/US2010/056340 WO2011060135A1 (en) | 2009-11-12 | 2010-11-11 | Subpopulations of spore-like cells and uses thereof |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015086621A Division JP2015130887A (ja) | 2009-11-12 | 2015-04-21 | 胞子様細胞の亜集団およびその用途 |
| JP2017071161A Division JP2017113037A (ja) | 2009-11-12 | 2017-03-31 | 胞子様細胞の亜集団およびその用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013510577A JP2013510577A (ja) | 2013-03-28 |
| JP2013510577A5 true JP2013510577A5 (enExample) | 2013-12-26 |
Family
ID=43478214
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012538970A Withdrawn JP2013510577A (ja) | 2009-11-12 | 2010-11-11 | 胞子様細胞の亜集団およびその用途 |
| JP2015086621A Pending JP2015130887A (ja) | 2009-11-12 | 2015-04-21 | 胞子様細胞の亜集団およびその用途 |
| JP2017071161A Withdrawn JP2017113037A (ja) | 2009-11-12 | 2017-03-31 | 胞子様細胞の亜集団およびその用途 |
| JP2018102188A Pending JP2018126171A (ja) | 2009-11-12 | 2018-05-29 | 胞子様細胞の亜集団およびその用途 |
| JP2018221096A Pending JP2019030336A (ja) | 2009-11-12 | 2018-11-27 | 胞子様細胞の亜集団およびその用途 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015086621A Pending JP2015130887A (ja) | 2009-11-12 | 2015-04-21 | 胞子様細胞の亜集団およびその用途 |
| JP2017071161A Withdrawn JP2017113037A (ja) | 2009-11-12 | 2017-03-31 | 胞子様細胞の亜集団およびその用途 |
| JP2018102188A Pending JP2018126171A (ja) | 2009-11-12 | 2018-05-29 | 胞子様細胞の亜集団およびその用途 |
| JP2018221096A Pending JP2019030336A (ja) | 2009-11-12 | 2018-11-27 | 胞子様細胞の亜集団およびその用途 |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US8551775B2 (enExample) |
| EP (1) | EP2499240A1 (enExample) |
| JP (5) | JP2013510577A (enExample) |
| KR (3) | KR102173873B1 (enExample) |
| CN (2) | CN104726394B (enExample) |
| AU (4) | AU2010319502B2 (enExample) |
| BR (1) | BR112012011183A2 (enExample) |
| CA (1) | CA2780549C (enExample) |
| IL (4) | IL219702A (enExample) |
| IN (1) | IN2012DN05181A (enExample) |
| WO (1) | WO2011060135A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102173873B1 (ko) * | 2009-11-12 | 2020-11-04 | 브이셀 세라퓨틱스 인코포레이티드 | 포자를 닮은 세포들의 계군 및 그 용도 |
| EP2734618B1 (en) * | 2011-07-20 | 2017-06-14 | Paracelsus Medizinische Privatuniversität Salzburg - Privatstiftung | Pluripotent tendon and ligament perivascular cells |
| KR101495281B1 (ko) * | 2014-01-10 | 2015-02-24 | (주)안트로젠 | 피부 재생 또는 상처 치유를 위한 중간엽 줄기세포-하이드로겔-생분해성 또는 중간엽 줄기세포-하이드로겔-비분해성 지지체 조성물 |
| MX380367B (es) | 2015-05-19 | 2025-03-12 | Scient Protein Laboratories Llc | Metodo para reducir o inactivar contenido viral o microbiano en los procesos para la fabricacion de pancreatina. |
| EP3371232B1 (en) | 2015-11-03 | 2021-01-06 | LORD Corporation | Two-parts adhesive system |
| US11435350B2 (en) * | 2018-09-18 | 2022-09-06 | Medeor Therapeutics, Inc. | Methods of analysis of blood from deceased donors |
Family Cites Families (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4060081A (en) | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
| US4188373A (en) | 1976-02-26 | 1980-02-12 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
| DE2657370C2 (de) | 1976-12-17 | 1982-11-11 | Hans Dr.med. Dr.med.dent. 8000 München Scheicher | Mittel zum Bedecken und/oder Ausfüllen von Knochendefekten |
| US4352883A (en) | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
| US4419936A (en) | 1980-04-11 | 1983-12-13 | The United States Of America As Represented By The Secretary Of The Army | Ballistic projectile |
| US4474752A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
| US4478822A (en) | 1983-05-16 | 1984-10-23 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
| US4474753A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Topical drug delivery system utilizing thermosetting gels |
| US4474751A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
| US4997443A (en) | 1985-08-26 | 1991-03-05 | Hana Biologics, Inc. | Transplantable artificial tissue and process |
| US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| US5041138A (en) | 1986-11-20 | 1991-08-20 | Massachusetts Institute Of Technology | Neomorphogenesis of cartilage in vivo from cell culture |
| US5804178A (en) | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
| US5567612A (en) | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
| CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| US4846835A (en) | 1987-06-15 | 1989-07-11 | Grande Daniel A | Technique for healing lesions in cartilage |
| US5786216A (en) | 1987-11-17 | 1998-07-28 | Cytotherapeutics, Inc. | Inner-supported, biocompatible cell capsules |
| US5575815A (en) | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
| IL90690A0 (en) | 1988-09-30 | 1990-01-18 | Organogenesis Inc | Tissue equivalents and their preparation |
| US5126141A (en) | 1988-11-16 | 1992-06-30 | Mediventures Incorporated | Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides |
| US5082670A (en) | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
| US5650148A (en) | 1988-12-15 | 1997-07-22 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| WO1991001720A1 (en) | 1989-08-07 | 1991-02-21 | Herman Wade Schlameus | Composition and method of promoting hard tissue healing |
| US5411883A (en) | 1989-12-26 | 1995-05-02 | Somatix Therapy Corporation | Proliferated neuron progenitor cell product and process |
| US5292655A (en) | 1990-01-29 | 1994-03-08 | Wille Jr John J | Method for the formation of a histologically-complete skin substitute |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5306501A (en) | 1990-05-01 | 1994-04-26 | Mediventures, Inc. | Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers |
| US5298260A (en) | 1990-05-01 | 1994-03-29 | Mediventures, Inc. | Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality |
| US5292516A (en) | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
| US5300295A (en) | 1990-05-01 | 1994-04-05 | Mediventures, Inc. | Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH |
| US5077033A (en) | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
| US5071644A (en) | 1990-08-07 | 1991-12-10 | Mediventures, Inc. | Topical drug delivery with thermo-irreversible gels |
| US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| US5529914A (en) | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
| DE69133205T2 (de) | 1990-10-19 | 2003-12-11 | New York University, New York | Eine methode zur transplantation von zellen in das gehirn und ihre therapeutische verwendung |
| US5192326A (en) | 1990-12-21 | 1993-03-09 | Pfizer Hospital Products Group, Inc. | Hydrogel bead intervertebral disc nucleus |
| CA2082411A1 (en) | 1991-06-28 | 1992-12-29 | Robert D. Rosenberg | Localized oligonucleotide therapy |
| US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
| US5750376A (en) | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
| US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
| JPH07501103A (ja) | 1991-11-12 | 1995-02-02 | ネペラ インコーポレイテッド | 長い使用寿命をもつ接着性ヒドロゲルおよびその調製法 |
| CA2137275A1 (en) | 1992-06-03 | 1993-12-09 | Richard L. Eckert | Bandage for continuous application of biologicals |
| AU4543193A (en) | 1992-06-22 | 1994-01-24 | Henry E. Young | Scar inhibitory factor and use thereof |
| AU678988B2 (en) | 1992-07-27 | 1997-06-19 | California Institute Of Technology | Mammalian multipotent neural stem cells |
| US5589376A (en) | 1992-07-27 | 1996-12-31 | California Institute Of Technology | Mammalian neural crest stem cells |
| US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
| US5766948A (en) | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
| US5512600A (en) | 1993-01-15 | 1996-04-30 | Massachusetts Institute Of Technology | Preparation of bonded fiber structures for cell implantation |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| DE4431598C2 (de) | 1993-03-03 | 1997-03-20 | Michael Sittinger | Verfahren zum Herstellen eines Implantates aus Zellkulturen |
| DE4306661C2 (de) | 1993-03-03 | 1995-04-20 | Michael Dipl Biol Sittinger | Verfahren zum Herstellen eines Implantates aus Zellkulturen |
| WO1994025079A1 (en) | 1993-04-23 | 1994-11-10 | Massachusetts Institute Of Technology | Porous biodegradable polymeric materials for cell transplantation |
| US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
| US5523226A (en) | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
| US5776747A (en) | 1994-07-20 | 1998-07-07 | Cytotherapeutics, Inc. | Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer |
| US5834029A (en) | 1994-07-20 | 1998-11-10 | Cytotherapeutics, Inc. | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment |
| US5827742A (en) | 1994-09-01 | 1998-10-27 | Beth Israel Deaconess Medical Center, Inc. | Method of selecting pluripotent hematopioetic progenitor cells |
| KR970707272A (ko) | 1994-11-14 | 1997-12-01 | 스코트 디. 코르맥 | 신경 간세포 증식 조절 방법(regulation of neural stem cell proliferation) |
| US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US5855610A (en) | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
| US5830651A (en) | 1995-06-01 | 1998-11-03 | Signal Pharmaceuticals, Inc. | Human oligodendroglial progenitor cell line |
| US5800811A (en) | 1995-06-06 | 1998-09-01 | Hall; Frederick L. | Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site |
| US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
| US5780300A (en) | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
| WO1997015655A2 (de) | 1995-10-20 | 1997-05-01 | Michael Sittinger | Neue künstliche gewebe, verfahren zu ihrer herstellung und ihre verwendung |
| ATE258810T1 (de) | 1995-11-09 | 2004-02-15 | Univ Massachusetts | Wiederherstellung der gewebeoberfläche mit zusammensetzungen aus hydrogel-zellen |
| ATE439849T1 (de) | 1996-04-19 | 2009-09-15 | Osiris Therapeutics Inc | Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen |
| US6497875B1 (en) | 1996-04-26 | 2002-12-24 | Case Western Reserve University | Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells |
| US5753506A (en) | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
| JP3754708B2 (ja) | 1996-06-04 | 2006-03-15 | ツィマー ゲーエム ベーハー | 軟骨内及び骨軟骨欠損を修復するための軟骨組織及びインプラントの製造方法並びにその方法を実施するための配置 |
| US6518236B1 (en) | 1996-10-16 | 2003-02-11 | Zymogenetics, Inc. | FGF homologs |
| TW528600B (en) | 1996-11-20 | 2003-04-21 | Yasuhiko Shimizu | Artificial neural canal |
| KR100532178B1 (ko) | 1996-11-27 | 2005-12-01 | 제넨테크, 인크. | 인간화 항-ＣＤ11ａ 항체 |
| WO1998024385A1 (en) | 1996-12-06 | 1998-06-11 | Tapic International Co., Ltd. | Artificial blood vessel |
| JP3632344B2 (ja) | 1997-01-06 | 2005-03-23 | 日産自動車株式会社 | 半導体装置 |
| US6638763B1 (en) | 1997-01-07 | 2003-10-28 | University Of Tennessee Research Foundation | Isolated mammalian neural stem cells, methods of making such cells |
| US6027744A (en) | 1998-04-24 | 2000-02-22 | University Of Massachusetts Medical Center | Guided development and support of hydrogel-cell compositions |
| US7575921B2 (en) * | 1999-12-30 | 2009-08-18 | Vbi Technologies, L.L.C. | Spore-like cells and uses thereof |
| CA2395117C (en) * | 1999-12-30 | 2016-03-22 | University Of Massachusetts | Spore-like cells and uses thereof |
| US7560275B2 (en) * | 1999-12-30 | 2009-07-14 | Vbi Technologies, L.L.C. | Compositions and methods for generating skin |
| WO2002057428A1 (en) * | 2000-10-30 | 2002-07-25 | University Of Massachusetts | Isolation of spore-like cells from tissues exposed to extreme conditions |
| JP4183614B2 (ja) * | 2001-05-31 | 2008-11-19 | 伸弥 山中 | Ｅｓ細胞特異的発現遺伝子 |
| US7208317B2 (en) | 2002-05-02 | 2007-04-24 | The University Of North Carolina At Chapel Hill | In Vitro mutagenesis, phenotyping, and gene mapping |
| KR100451409B1 (ko) | 2002-10-15 | 2004-10-06 | 한국전자통신연구원 | 마이크로 광스위치 및 그 제조방법 |
| JP2004213087A (ja) | 2002-12-26 | 2004-07-29 | Toshiba Corp | 個人認証装置および個人認証方法 |
| JP2005151907A (ja) | 2003-11-27 | 2005-06-16 | Shigeo Saito | 胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法 |
| US20050186672A1 (en) * | 2004-01-27 | 2005-08-25 | Reliance Life Sciences Pvt. Ltd. | Tissue system with undifferentiated stem cells derived from corneal limbus |
| US7310147B2 (en) | 2005-01-27 | 2007-12-18 | Genetix Limited | Robotic apparatus for picking of cells and other applications with integrated spectroscopic capability |
| ES2325715B1 (es) * | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca. |
| JP2009055866A (ja) * | 2007-08-31 | 2009-03-19 | Univ Kinki | 滑膜組織由来の幹細胞および細胞株ならびにその濃縮培養方法 |
| JP2009195142A (ja) * | 2008-02-20 | 2009-09-03 | Institute Of Physical & Chemical Research | 肝臓卵形細胞の取得方法 |
| AU2009234423A1 (en) | 2008-04-07 | 2009-10-15 | Nupotential, Inc. | Reprogramming a cell by inducing a pluripotent gene through RNA interference |
| KR102173873B1 (ko) * | 2009-11-12 | 2020-11-04 | 브이셀 세라퓨틱스 인코포레이티드 | 포자를 닮은 세포들의 계군 및 그 용도 |
-
2010
- 2010-11-11 KR KR1020197031906A patent/KR102173873B1/ko not_active Expired - Fee Related
- 2010-11-11 EP EP10779188A patent/EP2499240A1/en not_active Ceased
- 2010-11-11 KR KR1020187021471A patent/KR102081356B1/ko not_active Expired - Fee Related
- 2010-11-11 KR KR1020127015164A patent/KR20120089339A/ko not_active Ceased
- 2010-11-11 AU AU2010319502A patent/AU2010319502B2/en not_active Ceased
- 2010-11-11 CA CA2780549A patent/CA2780549C/en active Active
- 2010-11-11 BR BR112012011183A patent/BR112012011183A2/pt not_active Application Discontinuation
- 2010-11-11 WO PCT/US2010/056340 patent/WO2011060135A1/en not_active Ceased
- 2010-11-11 CN CN201510088784.2A patent/CN104726394B/zh not_active Expired - Fee Related
- 2010-11-11 JP JP2012538970A patent/JP2013510577A/ja not_active Withdrawn
- 2010-11-11 IN IN5181DEN2012 patent/IN2012DN05181A/en unknown
- 2010-11-11 US US12/944,342 patent/US8551775B2/en not_active Expired - Fee Related
- 2010-11-11 CN CN201080059186.8A patent/CN102762720B/zh not_active Expired - Fee Related
-
2012
- 2012-05-09 IL IL219702A patent/IL219702A/en active IP Right Grant
-
2013
- 2013-09-12 US US14/025,528 patent/US9145545B2/en active Active
-
2014
- 2014-09-10 AU AU2014221319A patent/AU2014221319A1/en not_active Abandoned
-
2015
- 2015-04-21 JP JP2015086621A patent/JP2015130887A/ja active Pending
- 2015-09-04 US US14/845,641 patent/US9663765B2/en not_active Expired - Fee Related
-
2016
- 2016-09-22 US US15/272,797 patent/US9999638B2/en active Active
-
2017
- 2017-03-31 JP JP2017071161A patent/JP2017113037A/ja not_active Withdrawn
- 2017-04-24 AU AU2017202703A patent/AU2017202703A1/en not_active Abandoned
- 2017-05-04 IL IL252113A patent/IL252113B/en active IP Right Grant
-
2018
- 2018-05-29 JP JP2018102188A patent/JP2018126171A/ja active Pending
- 2018-06-17 IL IL260067A patent/IL260067B/en active IP Right Grant
- 2018-06-18 US US16/011,284 patent/US11028363B2/en not_active Expired - Fee Related
- 2018-11-27 JP JP2018221096A patent/JP2019030336A/ja active Pending
-
2019
- 2019-06-12 AU AU2019204103A patent/AU2019204103B2/en not_active Ceased
-
2020
- 2020-05-03 IL IL274395A patent/IL274395B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Suman et al. | Potential clinical applications of stem cells in regenerative medicine | |
| Ratajczak et al. | A novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells | |
| Mothe et al. | Advances in stem cell therapy for spinal cord injury | |
| Li et al. | Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage | |
| Nekanti et al. | Long-term expansion and pluripotent marker array analysis of Wharton’s jelly-derived mesenchymal stem cells | |
| Shaikh et al. | Mouse bone marrow VSELs exhibit differentiation into three embryonic germ lineages and germ & hematopoietic cells in culture | |
| Wakao et al. | M use cells, newly found non‐tumorigenic pluripotent stem cells, reside in human mesenchymal tissues | |
| Rinaldi et al. | Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks | |
| Lee et al. | Maintenance and characterization of multipotent mesenchymal stem cells isolated from canine umbilical cord matrix by collagenase digestion | |
| Pozzobon et al. | ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective | |
| Abu Kasim et al. | Unique molecular signatures influencing the biological function and fate of post‐natal stem cells isolated from different sources | |
| JP2013510577A5 (enExample) | ||
| Yang et al. | A simple and efficient method for generating Nurr1-positive neuronal stem cells from human wisdom teeth (tNSC) and the potential of tNSC for stroke therapy | |
| Lee et al. | Sequential sub-passage decreases the differentiation potential of canine adipose-derived mesenchymal stem cells | |
| Ratajczak et al. | Stem cells for neural regeneration-a potential application of very small embryonic-like stem cells | |
| Khanabdali et al. | Promoting effect of small molecules in cardiomyogenic and neurogenic differentiation of rat bone marrow-derived mesenchymal stem cells | |
| Wakao et al. | The elite and stochastic model for iPS cell generation: Multilineage‐differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells | |
| Shin et al. | Very small embryonic-like stem-cell optimization of isolation protocols: an update of molecular signatures and a review of current in vivo applications | |
| Shi et al. | Urine-derived induced pluripotent/neural stem cells for modeling neurological diseases | |
| JP2016519939A5 (enExample) | ||
| Gericota et al. | Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury | |
| JPWO2017214342A5 (enExample) | ||
| Zhang et al. | The neural plasticity of early‐passage human bone marrow‐derived mesenchymal stem cells and their modulation with chromatin‐modifying agents | |
| Du et al. | hiPSC-neural stem/progenitor cell transplantation therapy for spinal cord injury | |
| Arrighi | Stem cells: therapeutic innovations under control |